David Ardron

928 total citations · 1 hit paper
9 papers, 588 citations indexed

About

David Ardron is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Ardron has authored 9 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in General Health Professions and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Ardron's work include Clinical practice guidelines implementation (2 papers), Pleural and Pulmonary Diseases (2 papers) and Brain Metastases and Treatment (2 papers). David Ardron is often cited by papers focused on Clinical practice guidelines implementation (2 papers), Pleural and Pulmonary Diseases (2 papers) and Brain Metastases and Treatment (2 papers). David Ardron collaborates with scholars based in United Kingdom, Australia and Switzerland. David Ardron's co-authors include Corinne Faivre‐Finn, N. Bayman, Tanya Holt, Kathryn Waite, Rachael Barton, Ruth E. Langley, Matthew Nankivell, Elaine McColl, Cheryl Pugh and I. Brisbane and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Ardron

9 papers receiving 577 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

2016 453 citations P. Mulvenna, Matthew Nankivell et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Ardron United Kingdom	7	448	344	186	66	62	9	588
Jordan A. Holmes United States	13	182 0.4×	118 0.3×	103 0.6×	39 0.6×	63 1.0×	53	439
Edward Yu Canada	13	249 0.6×	143 0.4×	42 0.2×	32 0.5×	34 0.5×	27	434
Solange Mongoue‐Tchokote United States	12	170 0.4×	127 0.4×	98 0.5×	28 0.4×	51 0.8×	23	451
Corinna Fritz Austria	6	176 0.4×	133 0.4×	58 0.3×	44 0.7×	22 0.4×	10	290
Helen G. Juffs Canada	7	317 0.7×	239 0.7×	162 0.9×	29 0.4×	19 0.3×	9	516
Archana Radhakrishnan United States	12	106 0.2×	206 0.6×	50 0.3×	69 1.0×	40 0.6×	45	452
P. Hopwood United Kingdom	8	174 0.4×	186 0.5×	28 0.2×	38 0.6×	43 0.7×	29	390
Claudio Verusio Italy	15	310 0.7×	371 1.1×	21 0.1×	23 0.3×	50 0.8×	54	604
Sewit Teckie United States	15	131 0.3×	190 0.6×	29 0.2×	34 0.5×	24 0.4×	39	514
Grace Musto Canada	13	121 0.3×	194 0.6×	49 0.3×	23 0.3×	76 1.2×	26	413

Countries citing papers authored by David Ardron

Since Specialization

Citations

This map shows the geographic impact of David Ardron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ardron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ardron more than expected).

Fields of papers citing papers by David Ardron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ardron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ardron. The network helps show where David Ardron may publish in the future.

Co-authorship network of co-authors of David Ardron

This figure shows the co-authorship network connecting the top 25 collaborators of David Ardron. A scholar is included among the top collaborators of David Ardron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ardron. David Ardron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bayman, N., David Ardron, Linda Ashcroft, et al.. (2016). Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention. BMJ Open. 6(1). e010589–e010589. 16 indexed citations

Mulvenna, P., Matthew Nankivell, Rachael Barton, et al.. (2016). Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. The Lancet. 388(10055). 2004–2014. 453 indexed citations breakdown →

Raine, Rosalind, Penny Xanthopoulou, Isla Wallace, et al.. (2015). Use of a formal consensus development technique to produce recommendations for improving the effectiveness of adult mental health multidisciplinary team meetings. BMC Psychiatry. 15(1). 143–143. 12 indexed citations

Mulvenna, P., Matthew Nankivell, Rachael Barton, et al.. (2015). Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061).. Journal of Clinical Oncology. 33(15_suppl). 8005–8005. 21 indexed citations

Collins, Karen, et al.. (2014). Making patient and public involvement in cancer and palliative research a reality: academic support is vital for success. BMJ Supportive & Palliative Care. 5(2). 203–206. 17 indexed citations

Raine, Rosalind, Isla Wallace, Penny Xanthopoulou, et al.. (2014). Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study. SHILAP Revista de lepidopterología. 2(37). 1–172. 59 indexed citations

Trimble, Edward L., JA Ledermann, Kate Law, et al.. (2012). International models of investigator-initiated trials: implications for Japan. Annals of Oncology. 23(12). 3151–3155. 2 indexed citations

Bayman, N., Linda Ashcroft, David Ardron, et al.. (2012). 69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention. Lung Cancer. 75. S23–S23. 2 indexed citations

Ardron, David, et al.. (2010). Patient and public involvement in health research: what is it, and why is it so important?. International Journal of Palliative Nursing. 16(4). 160–162. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact